Clinical decision support
Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New Zealand, and Asia.
The LLM-based tool, developed by researchers from Yonsei University College of Medicine, automatically generates legally required discharge notes in the emergency department.
It shows potential for early, opportunistic screening for osteoporosis without a separate bone density test, according to Seoul National University Hospital researchers.
The Korean AI company also plans expansion into Vietnam and Hong Kong.
Trained on local medical laws and treatment guidelines, the model scored 96.4 on the 2025 Korean Medical Licensing Examination.
The model can also make zero-shot predictions.
Also, South Korea's Ministry of Health and Welfare has made more patient data available on the My Health Record app.
It demonstrated over 90% accuracy in detecting binary foetal movements in a hospital trial.
Also, a Taiwanese consortium is expanding across the Japanese elderly care sector.
Also, Topcon acquires New Zealand-founded Toku to expand access to AI-based health screening using retinal images.